Yasushi Shimo - Related publications

Juntendo University, Chiyoda-ku, Tōkyō-to, Japan 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Krause E, Randhawa J, Mehanna R. Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph™. Parkinsonism & Related Disorders. 87: 105-110. PMID 34020301 DOI: 10.1016/j.parkreldis.2021.05.008   
2021 Kim Y, Suescun J, Schiess MC, Jiang X. Computational medication regimen for Parkinson's disease using reinforcement learning. Scientific Reports. 11: 9313. PMID 33927277 DOI: 10.1038/s41598-021-88619-4   
2021 Li C, Hou Y, Wang X, Li YX, Li F, Zhang C, Li WG. Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota. Frontiers in Neurology. 12: 653833. PMID 33889128 DOI: 10.3389/fneur.2021.653833   
2021 Mahajan A, Butala A, Okun MS, Mari Z, Mills KA. Global Variability in Deep Brain Stimulation Practices for Parkinson's Disease. Frontiers in Human Neuroscience. 15: 667035. PMID 33867961 DOI: 10.3389/fnhum.2021.667035   
2021 Damron L, Litvan I, Bayram E, Berk S, Siddiqi B, Shill H. Hispanic Perspectives on Parkinson's Disease Care and Research Participation. Journal of Alzheimer's Disease : Jad. PMID 33843687 DOI: 10.3233/JAD-210231   
2021 Kuai XY, Yao XH, Xu LJ, Zhou YQ, Zhang LP, Liu Y, Pei SF, Zhou CL. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation. Microbial Cell Factories. 20: 98. PMID 33985520 DOI: 10.1186/s12934-021-01589-0   
2021 McIntosh E, Kent S, Gray A, Clarke CE, Williams A, Jenkinson C, Ives N, Patel S, Rick C, Wheatley K, Gray R, . Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33960511 DOI: 10.1002/mds.28623   
2021 Waggan I, Rissanen E, Tuisku J, Matilainen M, Helin S, Parkkola R, Rinne JO, Airas L. Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease. Parkinsonism & Related Disorders. 86: 40-44. PMID 33831661 DOI: 10.1016/j.parkreldis.2021.03.030   
2021 Schmidt N, Tödt I, Berg D, Schlenstedt C, Folkerts AK, Ophey A, Dimenshteyn K, Elben S, Wojtecki L, Liepelt-Scarfone I, Schulte C, Sulzer P, Eggers C, Kalbe E, Witt K. Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial. Journal of Neurology. PMID 33904966 DOI: 10.1007/s00415-021-10568-9   
2021 Artusi CA, Romagnolo A, Ledda C, Zibetti M, Rizzone MG, Montanaro E, Bozzali M, Lopiano L. COVID-19 and Parkinson's Disease: What Do We Know So Far? Journal of Parkinson's Disease. 11: 445-454. PMID 33749619 DOI: 10.3233/JPD-202463   
2021 Bos MJ, de Korte-de Boer D, Alzate Sanchez AM, Duits A, Ackermans L, Temel Y, Absalom AR, Buhre WF, Roberts MJ, Janssen MLF. Impact of Procedural Sedation on the Clinical Outcome of Microelectrode Recording Guided Deep Brain Stimulation in Patients with Parkinson's Disease. Journal of Clinical Medicine. 10. PMID 33917205 DOI: 10.3390/jcm10081557   
2021 Li J, Mei S, Jia X, Zhang Y. Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease. Frontiers in Neurology. 12: 595741. PMID 33912121 DOI: 10.3389/fneur.2021.595741   
2021 Erro R, Landolfi A, D'Agostino G, Pace L, Picillo M, Scarano M, Cuocolo A, Pappatá S, Vitale C, Pellecchia MT, Monteleone P, Barone P. Bipolar Disorder and Parkinson's Disease: A I-Ioflupane Dopamine Transporter SPECT Study. Frontiers in Neurology. 12: 652375. PMID 33927683 DOI: 10.3389/fneur.2021.652375   
2021 De Michele G, Palmieri GR, Pane C, Dello Iacovo CDP, Perillo S, Saccà F, De Michele G, De Rosa A. Othello syndrome in Parkinson's disease: a systematic review and report of a case series. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 33978871 DOI: 10.1007/s10072-021-05249-4   
2021 Hansen RN, Suh K, Serbin M, Yonan C, Sullivan SD. Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson's disease patients treated with levodopa/carbidopa. Journal of Medical Economics. 24: 563-569. PMID 33866942 DOI: 10.1080/13696998.2021.1916750   
2021 Chang CN, Niu CY, Tan AC, Chan CH, Chen CF, Chen TH, Li SY, Chen YT, Chen FY, Liu WS, Lin CC, Wei GJ. The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis. International Journal of Molecular Sciences. 22. PMID 33918516 DOI: 10.3390/ijms22073732   
2021 Chen W, Caplin N, El Shamy O, Sharma S, Sourial MY, Ross MJ, Sourial MH, Prudhvi K, Golestaneh L, Srivatana V, Dalsan R, Shimonov D, Sanchez-Russo L, Atallah S, Uribarri J, , et al. Use of Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic in New York City: A multicenter observational study. Kidney International. PMID 33930411 DOI: 10.1016/j.kint.2021.04.017   
2021 Barker RA, Cutting EV, Daft DM. Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective. Journal of Parkinson's Disease. PMID 33814466 DOI: 10.3233/JPD-212563   
2021 Santos García D, Labandeira Guerra C, Yáñez Baña R, Cimas Hernando MI, Cabo López I, Paz Gonález JM, Alonso Losada MG, González Palmás MJ, Martínez Miró C. Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study. Brain Sciences. 11. PMID 33801565 DOI: 10.3390/brainsci11030316   
2021 Kodaka N, Nakano C, Oshio T, Watanabe K, Niitsuma K, Imaizumi C, Shimada N, Morita H, Matsuse H. Exacerbating factors in elderly patients with complex pulmonary disease. Epidemiology and Infection. 149: e117. PMID 33902774 DOI: 10.1017/S0950268821000960   
2021 Tomura M, Hamasaki Y, Komaru Y, Miyamoto Y, Matsuura R, Matsumoto A, Doi K, Kume H, Nangaku M. Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation. Bmc Nephrology. 22: 135. PMID 33863299 DOI: 10.1186/s12882-021-02321-1   
2021 Chen X, Hua L, Zhang C, Xu Z, Cao X, Cai Y. Effect of peer support on improving self-management ability in peritoneal dialysis patients-a randomized controlled trial. Annals of Palliative Medicine. 10: 3028-3038. PMID 33849093 DOI: 10.21037/apm-21-219   
2021 Eichhorn F, Kriegsmann M, Klotz LV, Kriegsmann K, Muley T, Zgorzelski C, Christopoulos P, Winter H, Eichhorn ME. Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis. Cancers. 13. PMID 33922610 DOI: 10.3390/cancers13092046   
2021 Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, Serrano GE, Adler CH, Perlman SL, Poon WW, Kang UJ, et al. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy. Acta Neuropathologica. PMID 33991233 DOI: 10.1007/s00401-021-02324-0   
2021 Xie T, Liao C, Lee D, Yu H, Padmanaban M, Kang W, Johnson J, Alshaikh J, Yuen C, Burns M, Chiu BC. Disparities in diagnosis, treatment and survival between Black and White Parkinson patients. Parkinsonism & Related Disorders. 87: 7-12. PMID 33905958 DOI: 10.1016/j.parkreldis.2021.04.013   
2021 Pires da Silva I, Ahmed T, Reijers ILM, Weppler AM, Betof Warner A, Patrinely JR, Serra-Bellver P, Allayous C, Mangana J, Nguyen K, Zimmer L, Trojaniello C, Stout D, Lyle M, Klein O, et al. Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. The Lancet. Oncology. PMID 33989557 DOI: 10.1016/S1470-2045(21)00097-8   
2021 Klein O, Senko C, Carlino MS, Markman B, Jackett L, Gao B, Lum C, Kee D, Behren A, Palmer J, Cebon J. Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538. Oncoimmunology. 10: 1908771. PMID 33889439 DOI: 10.1080/2162402X.2021.1908771   
2021 Valentin J, Ferté T, Dorizy-Vuong V, Dousset L, Prey S, Dutriaux C, Pham-Ledard A, Beylot-Barry M, Gérard E. Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study. Journal of Oncology. 2021: 5524685. PMID 33995528 DOI: 10.1155/2021/5524685   
2021 Koomen BM, van der Starre-Gaal J, Vonk JM, von der Thüsen JH, van der Meij JJC, Monkhorst K, Willems SM, Timens W, 't Hart NA. Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer. Cancer Cytopathology. 129: 304-317. PMID 33108706 DOI: 10.1002/cncy.22383   
2021 Ahn S, Kim KM. PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 34002009 DOI: 10.1038/s41379-021-00823-9   
2021 Grenda A, Krawczyk P, Kucharczyk T, Błach J, Reszka K, Chmielewska I, Buczkowski J, Kieszko R, Siwiec J, Kubiatowski T, Bożyk A, Krukowska K, Jarosz B, Paśnik I, Pankowski J, et al. Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma. Oncology Letters. 21: 449. PMID 33868487 DOI: 10.3892/ol.2021.12710   
2021 Liu Z, Liu C, Yao W, Gao S, Wang J, Zhang P, Ge H. Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study. Anti-Cancer Drugs. PMID 34001702 DOI: 10.1097/CAD.0000000000001088   
2021 Mihray A, Chen P. [Research Progress on Heterogeneity of Tumor Mutation Burden in Patients with 
Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 24: 293-298. PMID 33910278 DOI: 10.3779/j.issn.1009-3419.2021.102.12   
2021 Meng X, Wu W, Xu S, Cheng Z. Comparison of outcomes of peritoneal dialysis between patients after failed kidney transplant and transplant-naïve patients: a meta-analysis of observational studies. Renal Failure. 43: 698-708. PMID 33896379 DOI: 10.1080/0886022X.2021.1914659   
2021 Rong Z, Shen F, Wang Y, Sun L, Wu J, Zhang H, Yuan Y, Jiang W, Li X, Ji P, Zhang K. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis. Neuroscience Letters. 135964. PMID 34022266 DOI: 10.1016/j.neulet.2021.135964   
2021 Achenbach J, Saft C, Faissner S. Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington's Disease-Data from a Real World Cohort. Brain Sciences. 11. PMID 33805940 DOI: 10.3390/brainsci11040413   
2021 Peikert SA, Fischer A, Kruse AB, Al-Ahmad A, Woelber JP, Vach K, Braun A, Ratka-Krüger P. Adjuvant Transgingival Therapy with Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) in Periodontal Therapy-A Randomized, Controlled, Stratified, Double-Blinded Clinical Trial. Antibiotics (Basel, Switzerland). 10. PMID 33802497 DOI: 10.3390/antibiotics10030251   
2021 Quinn RR, Mohamed F, Pauly R, Schwartz T, Scott-Douglas N, Morrin L, Kozinski A, Manns BJ, Klarenbach S, Clarke A, Fox DE, Oliver MJ. Starting Dialysis on Time, At Home on the Right Therapy (START): Description of an Intervention to Increase the Safe and Effective Use of Peritoneal Dialysis. Canadian Journal of Kidney Health and Disease. 8: 20543581211003764. PMID 33868692 DOI: 10.1177/20543581211003764   
2021 Park JH, Yoon D, Lee J, Oh SJ, Kim HJ, Lee JH, Lee DY. Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a single tertiary center. The Journal of Dermatology. PMID 33878219 DOI: 10.1111/1346-8138.15824   
2021 Zheng DC, Bao JW, Guo JH, Xie MK, Li WJ, Wang Z. Effects of patients' understanding and choice of surgical types on postoperative outcomes of Peyronie's disease: a single-center retrospective study of 108 patients. Asian Journal of Andrology. PMID 33975988 DOI: 10.4103/aja.aja_32_21   
2021 Mok NM, Fan N, Finney H, Fan SL. Relationship between sodium removal, hydration and outcomes in peritoneal dialysis patients. Nephrology (Carlton, Vic.). PMID 33893694 DOI: 10.1111/nep.13885   
2021 Zhang F, Wu X, Wen Y, Zhan X, Peng FF, Wang X, Qian Z, Feng X. Hypomagnesemia Is a Risk Factor for Cardiovascular Disease- and Noncardiovascular Disease-Related Mortality in Peritoneal Dialysis Patients. Blood Purification. 1-8. PMID 33882494 DOI: 10.1159/000514148   
2021 Kong G, Wu J, Chu H, Yang C, Lin Y, Lin K, Shi Y, Wang H, Zhang L. Predicting Prolonged Length of Hospital Stay for Peritoneal Dialysis-Treated Patients Using Stacked Generalization: Model Development and Validation Study. Jmir Medical Informatics. 9: e17886. PMID 34009135 DOI: 10.2196/17886   
2021 Goutelle S, Conrad A, Pouderoux C, Braun E, Laurent F, Gagnieu MC, Cohen S, Guitton J, Valour F, Ferry T. Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection. Frontiers in Medicine. 8: 583086. PMID 33869238 DOI: 10.3389/fmed.2021.583086   
2021 Chen S, Li R, Zhang Z, Huang Z, Cui P, Jia W, Zhang S, Tao H, Wang L, Li X, Wang J, Ma J, Liu Z, Huang D, Zheng X, et al. Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors. Translational Lung Cancer Research. 10: 1397-1407. PMID 33889518 DOI: 10.21037/tlcr-21-43   
2021 Lee HM, Han KD, Suh JD, Cho JH. Uvulopalatopharyngoplasty may decrease the incidence of Parkinson's disease associated with obstructive sleep apnea. Scientific Reports. 11: 9608. PMID 33953319 DOI: 10.1038/s41598-021-89205-4   
2021 Zhang J, Lu X, Li H, Wang S. Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis. Renal Failure. 43: 743-753. PMID 33913381 DOI: 10.1080/0886022X.2021.1918558   
2021 Li Z, Li X, Lam W, Cao Y, Han H, Zhang X, Fang J, Xiao K, Zhou F. Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials. Frontiers in Oncology. 11: 629646. PMID 33869015 DOI: 10.3389/fonc.2021.629646   
2021 Mori Y, Sato H, Kumazawa T, Permata TBM, Yoshimoto Y, Murata K, Noda SE, Kaminuma T, Ando K, Oike T, Okonogi N, Okada K, Kakoti S, Suzuki K, Ikota H, et al. Analysis of radiotherapy-induced alteration of CD8 T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma. Oncology Letters. 21: 446. PMID 33868484 DOI: 10.3892/ol.2021.12707   
2021 Bu Y, Wang H, Ma X, Han C, Jia X, Zhang J, Liu Y, Peng Y, Yang M, Yu K, Wang C. Untargeted Metabolomic Profiling of the Correlation Between Prognosis Differences and PD-1 Expression in Sepsis: A Preliminary Study. Frontiers in Immunology. 12: 594270. PMID 33868224 DOI: 10.3389/fimmu.2021.594270